Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001193125-20-002234
Filing Date
2020-01-06
Accepted
2020-01-06 16:47:55
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-4/A d834396ds4a.htm S-4/A 3204927
2 EX-4.2 d834396dex42.htm EX-4.2 118106
3 EX-5.1 d834396dex51.htm EX-5.1 12812
4 EX-23.1 d834396dex231.htm EX-23.1 1749
5 EX-23.2 d834396dex232.htm EX-23.2 3879
6 EX-99.4 d834396dex994.htm EX-99.4 25020
7 EX-99.5 d834396dex995.htm EX-99.5 29208
8 GRAPHIC g83439623_2.jpg GRAPHIC 6469
9 GRAPHIC g834396g02y88.jpg GRAPHIC 47346
10 GRAPHIC g834396g03e54.jpg GRAPHIC 41679
11 GRAPHIC g834396g1221140326748.jpg GRAPHIC 1785
12 GRAPHIC g834396g12h60.gif GRAPHIC 2948
13 GRAPHIC g834396g14y23.jpg GRAPHIC 1727
14 GRAPHIC g834396g22t23.jpg GRAPHIC 27023
  Complete submission text file 0001193125-20-002234.txt   3575171
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-235351 | Film No.: 20510441
SIC: 2834 Pharmaceutical Preparations